
GRAS Notification Assessment & FDA Package Preparation
Evaluate food ingredients for GRAS status and prepare FDA notification packages
What You Can Do
You can conduct rigorous GRAS determinations by evaluating scientific evidence, synthesizing safety data, and determining the optimal regulatory pathway (self-affirmed vs. FDA notification). This skill guides you through the complete assessment process—from identifying relevant safety literature through assembling defensible documentation—ensuring your ingredient meets FDA's stringent evidentiary standards for GRAS status.
Features
Systematically evaluate ingredients against 21 CFR 170.30 requirements for general recognition of safety
Identify whether self-affirmed GRAS or FDA notification is appropriate for your ingredient
Compile and organize published research, historical use data, and toxicological evidence into coherent narratives
Structure expert consensus determination and identify qualified expert panel members for notification packages
Compile complete notification documents including ingredient specifications, safety summaries, and expert statements
Identify potential FDA objections and proactively address them in documentation
Evaluate ingredient safety against structurally similar substances with established safety profiles
Example Output
Example 1: Botanical Extract GRAS Assessment
- Ingredient: Polyphenol extract from plant species
- Historical use determination: Evidence of 50+ years use in traditional beverages (establishes reasonable history of consumption)
- Safety data summary: 12 peer-reviewed studies showing no adverse effects at proposed use levels; toxicology studies support safety margin of 100x
- Qualified expert consensus: Panel of 5 food safety experts unanimously agrees ingredient is GRAS
- Recommendation: Self-affirmed GRAS pathway appropriate; no FDA notification required
Example 2: Fermentation-Derived Ingredient FDA Notification Package
- Ingredient: Novel protease from engineered microorganism
- GRAS criteria: Limited historical use; substantial safety data from controlled studies
- Notification package contents: Chemistry/specifications, manufacturing controls, safety assessment (5 toxicology studies), intended use statement, expert qualifications and statements
- Regulatory pathways evaluated: FDA notification selected; self-affirmed GRAS insufficient due to genetic modification
- Expected FDA review timeline: 180 days from complete notification submission
What's Included
- SKILL.md instruction file: Complete GRAS assessment methodology and regulatory framework
- GRAS Criteria Evaluation Checklist: Itemized assessment against 21 CFR 170.30 requirements
- Safety Data Synthesis Template: Structured framework for organizing toxicology, history of use, and comparative data
- FDA Notification Package Outline: Section-by-section guide for assembling complete notification documentation
- Qualified Expert Panel Worksheet: Criteria and qualifications template for identifying appropriate expert evaluators
Who It's For
- Food regulatory specialists and compliance officers managing ingredient approval pathways
- Food scientists and R&D teams evaluating novel ingredients for market introduction
- Regulatory affairs managers preparing FDA communications and notifications
- Food manufacturers conducting due diligence on ingredient acquisitions
- Legal counsel advising on food ingredient regulatory strategy
Best For
- GRAS determination assessments for botanical extracts, fermentation-derived ingredients, or processing aids
- FDA notification package preparation for novel food ingredients with scientific support
- Regulatory pathway selection (self-affirmed vs. FDA notification) for new ingredients
- Safety data synthesis and expert consensus documentation for regulatory submission
- Anticipating and addressing potential FDA objections to ingredient GRAS status







